Real-world efficacy, safety, and clinical outcomes of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin combination therapy in patients with hepatitis C virus genotype 1 or 4 infection: The Turkey experience experience-Reference-Cited by-同舟云学术

Real-world efficacy, safety, and clinical outcomes of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin combination therapy in patients with hepatitis C virus genotype 1 or 4 infection: The Turkey experience experience

Published:2020-05-12 Issue:4 Volume:31 Page:305-317
ISSN:1300-4948
Container-title:The Turkish Journal of Gastroenterology
language:
Short-container-title:Turk J Gastroenterol

Author:

Aygen Bilgehan, ,Demirturk Nese,Yildiz Orhan,Celen Mustafa Kemal,Celik Ilhami,Barut Sener,Ural Onur,Batirel Ayse,Mistik Resit,Simsek Funda,Asan Ali,Ersoz Gulden,Turker Nesrin,Bilgin Huseyin,Kinikli Sami,Karakecili Faruk,Zararsiz Gokmen, , , , , , , , , , , , , , , ,

Publisher

AVES Publishing Co.

Subject

Gastroenterology

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Efficacy and Safety of Direct-Acting Antivirals in Chronic Hepatitis C Treatment: Real-World Data;Viral Hepatitis Journal;2023-12-26

2. Evaluation of Direct-Acting Antiviral Therapy Efficacy and Post-Treatment Fibrosis with Noninvasive Markers in Patients with Chronic Hepatitis C;Flora the Journal of Infectious Diseases and Clinical Microbiology;2023-12-22

3. Real-Life Data of Chronic Hepatitis C Patients Treated with Direct-Acting Oral Antivirals: A Single-Center Study;Istanbul Medical Journal;2023-05-31

4. Strategies for delivery of antiviral agents;Viral Infections and Antiviral Therapies;2023

5. Real-world efficacy and safety of Ledipasvir + Sofosbuvir and Om-bitasvir/Paritaprevir/Ritonavir ± Dasabuvir combination therapies for chronic hepatitis C: A Turkish experience;The Turkish Journal of Gastroenterology;2021-01-29